Permeation enhancers in transdermal drug delivery: benefits and limitations

被引:274
作者
Kovacik, Andrej [1 ]
Kopecna, Monika [1 ]
Vavrova, Katerina [1 ]
机构
[1] Charles Univ Prague, Fac Pharm Hradec Kralove, Skin Barrier Res Grp, Hradec Kralove, Czech Republic
关键词
Drug delivery; penetration enhancers; percutaneous absorption; permeabilization; skin barrier; transdermal; CHEMICAL PENETRATION ENHANCERS; IN-VITRO EVALUATION; STRATUM-CORNEUM; SKIN BARRIER; PERCUTANEOUS-ABSORPTION; OLEIC-ACID; MODEL MEMBRANES; AZONE ANALOGS; CHAIN; PERMEABILITY;
D O I
10.1080/17425247.2020.1713087
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Introduction: Transdermal drug delivery has several clinical benefits over conventional routes of drug administration. To open the transdermal route for a wider range of drugs, including macromolecules, numerous physical and chemical techniques to overcome the natural low skin permeability have been developed. Areas covered: This review focuses on permeation enhancers (penetration enhancers, percutaneous absorption promoters or accelerants), which are chemicals that increase drug flux through the skin barrier. First, skin components, drug permeation pathways, and drug properties are introduced. Next, we discuss properties of enhancers, their various classifications, structure-activity relationships, mechanisms of action, reversibility and toxicity, biodegradable enhancers, and synergistic enhancer combinations. Expert opinion: Overcoming the remarkable skin barrier properties in an efficient, temporary and safe manner remains a challenge. High permeation-enhancing potency has long been perceived to be associated with toxicity and irritation potential of such compounds, which has limited their further development. In addition, the complexity of enhancer interactions with skin, formulation and drug, along with their vast chemical diversity hampered understanding of their mechanisms of action. The recent development in the field revealed highly potent yet safe enhancers or enhancer combinations, which suggest that enhancer-aided transdermal drug delivery has yet to reach its full potential.
引用
收藏
页码:145 / 156
页数:12
相关论文
共 119 条
[1]   Chemical penetration enhancers: a patent review [J].
Ahad, Abdul ;
Aqil, Mohammed ;
Kohli, Kanchan ;
Chaudhary, Hema ;
Sultana, Yasmin ;
Mujeeb, Mohammed ;
Talegaonkar, Sushama .
EXPERT OPINION ON THERAPEUTIC PATENTS, 2009, 19 (07) :969-988
[2]   PERCUTANEOUS ABSORPTION - INVIVO EXPERIMENTS [J].
ALBERY, WJ ;
HADGRAFT, J .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1979, 31 (03) :140-147
[3]   FOURIER-TRANSFORM RAMAN-SPECTROSCOPY OF INTERACTIONS BETWEEN THE PENETRATION ENHANCER DIMETHYL-SULFOXIDE AND HUMAN STRATUM-CORNEUM [J].
ANIGBOGU, ANC ;
WILLIAMS, AC ;
BARRY, BW ;
EDWARDS, HGM .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1995, 125 (02) :265-282
[4]   Surfactant effects on the in vitro percutaneous absorption of diclofenac sodium [J].
Arellano, A ;
Santoyo, S ;
Martín, C ;
Ygartua, P .
EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 1998, 23 (02) :307-312
[5]  
Asbill CS, 2000, CRIT REV THER DRUG, V17, P621, DOI 10.1615/CritRevTherDrugCarrierSyst.v17.i6.20
[6]   Absorption Enhancers: Applications and Advances [J].
Aungst, Bruce J. .
AAPS JOURNAL, 2012, 14 (01) :10-18
[7]  
Babu RJ, 2015, PERCUTANEOUS PENETRA, P291
[8]  
Babu RJayachandra., 2015, Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement, P133
[9]  
BARRY B W, 1987, Journal of Controlled Release, V6, P85, DOI 10.1016/0168-3659(87)90066-6
[10]  
Barry B.W., 1983, DERMATOLOGICAL FORMU